Anticold Range

Anticold Range — Saturn Formulations PCD Pharma Franchise

Common cold, influenza-like illness, upper respiratory tract infections, and associated cough account for the largest number of outpatient visits in India's primary care system. With an estimated 500 million cold episodes annually across India's population, the demand for effective, safe, and affordable cold and cough medications remains consistently high throughout the year — and peaks dramatically during seasonal change. Saturn Formulations, a WHO-GMP and ISO-certified pharmaceutical company established in 2012, offers a clinically-backed Anticold Range that addresses the full spectrum of cold and respiratory symptom management from nasal decongestion and antihistamine relief to expectorant mucolytics and antipyretic-analgesic combinations.

Our anticold formulations are developed to provide multi-symptom relief while maintaining an acceptable safety profile — a balance that both prescribers and patients demand. All products are manufactured in our DCGI-approved facility and tested by NABL-accredited laboratories before reaching franchise partners.

Why Choose Saturn Formulations for Anticold Franchise?

• Multi-Symptom Combinations: Single-tablet combinations covering fever, congestion, cough, and allergy reduce patient pill burden and improve compliance.
• Seasonal Revenue Surge: Cold season (October–February) creates predictable high-revenue periods for franchise partners stocking anticold products.
• Year-Round Demand: Air conditioning-related rhinitis, dust allergy-driven cough, and infection exposure mean anticold products sell throughout the year.
• Wide Prescriber Base: General physicians, paediatricians, ENT surgeons, and pharmacists all recommend anticold products — maximising prescription and OTC opportunities.
• WHO-GMP Compliance: Manufacturing standards that ensure safe combinations without subtherapeutic dosing or adulteration.
• Monopoly Rights: Exclusive territorial rights to protect your anticold business investment.

Our Anticold Product Range

Decongestant and Antihistamine Combinations

Phenylephrine 5mg + Chlorpheniramine 2mg + Paracetamol 325mg — the classic cold combination that addresses fever, congestion, and sneezing simultaneously. Available in adult and paediatric tablet strengths. Pseudoephedrine-based decongestant combinations for cases requiring stronger nasal decongestion.

Expectorant and Mucolytic Products

Ambroxol Hydrochloride 30mg, 75mg SR tablets and syrup — the most prescribed mucolytic in India for productive cough. Bromhexine 8mg tablets and syrup for viscous mucus liquefaction. Guaifenesin 200mg and 400mg tablets for reflex secretion augmentation in dry cough. These products are stocked by virtually every pharmacy in India.

Antitussive Products

Dextromethorphan 10mg and 15mg tablets and syrups for dry, non-productive cough — particularly in post-viral upper respiratory illness. Codeine phosphate-containing linctuses (Schedule H, restricted) where appropriate for cough suppression in severe cases.

Multi-Symptom Cold Tablets

Advanced quadruple and quintuple combination cold tablets containing antihistamine, decongestant, antitussive, antipyretic, and analgesic in a single dosage form. These convenience combinations drive higher MRP and stronger margins for franchise partners targeting urban and semi-urban markets.

Throat Lozenges and Local Preparations

Benzocaine and Benzydamine throat lozenges for sore throat; antiseptic gargles and throat sprays. These adjunct products expand the franchise partner's basket size per customer visit.

Quality Assurance — Anticold Manufacturing

Multi-ingredient combination tablets require rigorous compatibility testing and content uniformity validation to ensure each active pharmaceutical ingredient achieves its specified dose in every tablet. Saturn Formulations' formulation development team conducts formal compatibility studies (API-API and API-excipient) before any new combination is taken to commercial scale.

Finished product testing for anticold tablets includes individual HPLC assay for each active ingredient, disintegration and dissolution profiling, and microbiological testing per IP specifications. Syrups and liquid formulations undergo additional viscosity measurement, pH testing, and preservative efficacy testing.

Market Opportunity — Anticold Franchise

The Indian cold and cough remedy market is valued at over INR 6,000 crore and continues to grow driven by urbanisation, pollution, and increasing healthcare access in rural areas. OTC-accessible cold products sold through pharmacies without prescription add to prescription-driven demand — giving franchise partners multiple revenue streams from the same product line.

Cold season promotions, pharmacy tie-up schemes, and general physician detailing during monsoon and winter months are proven strategies that Saturn Formulations' marketing team supports actively for all anticold franchise partners.

Begin Your Anticold PCD Franchise

1. Contact us: +91-8729000609 | enquiry.saturn@gmail.com
2. Select anticold SKUs — tablets, syrups, lozenges, or full range
3. Submit Drug License and GST documents
4. Confirm monopoly territory
5. Receive products and seasonal promotional materials

Saturn Formulations' anticold franchise gives you a powerful, year-round revenue-generating portfolio with exceptional seasonal upside. Connect with us today to get started.